Canadian Natural Resources enters its May 7 Q1 results with an interesting split in the data: the stock has recovered sharply from a rough month, yet shorts have been quietly rebuilding positions and the cost to borrow has spiked to its highest level in weeks.
The price recovery is real but incomplete. CNQ closed at CAD 63.44 on Tuesday, up 4.8% on the week and 3.3% on Tuesday alone. That claws back only part of an 8.7% slide over the prior month. Correlated peers broadly moved in the same direction — VET gained 8.8% on the week and WCP added 8.4%, suggesting the bid was sector-wide rather than stock-specific. EOG, the most liquid US analog, rose just 2.5%, pointing to a relative outperformance by the Canadian names.
The lending market tells a more cautious story. The cost to borrow has tripled over the past week, jumping from around 0.53% to 2.17% — the highest daily reading in the past six weeks. That shift arrived as short interest climbed by roughly 3.2 million shares around April 21, pushing the estimated position to 20.5 million shares, equivalent to just under 1% of the free float. That is not a large absolute level, but the week-on-week rise of 18.7% in share count is worth noting ahead of an earnings print. Borrow availability has been loosening steadily since mid-March — it was extraordinarily tight then, and today's conditions are far more benign — but the sudden CTB spike suggests demand for fresh shorts picked up sharply this week. The short score of 28.2 is low in absolute terms, though it ranks in the 83rd percentile of the universe, signalling that relative to history CNQ draws more short interest attention than most stocks in its class.
The Street broadly remains constructive. The consensus price target of CAD 69.95 implies roughly 10% upside from the current price — a gap that has held steady despite the recent sell-off. CNQ's factor scores point to genuine fundamental strength: EPS momentum ranks in the 93rd percentile over both 30 and 90 days, and the EPS surprise score is also in the 93rd percentile, meaning the company has been a consistent outperformer against expectations. The dividend score is 99 — essentially top-decile across the market. Valuation is not stretched: the PE has compressed sharply over the past month, falling by more than 7 points to 12.3x, while EV/EBITDA sits around 6.7x. At those multiples, and with operating cash flow running at over CAD 14 billion annually, the fundamental case for the stock is not hard to construct.
On the ownership side, Capital Research remains the dominant external shareholder at over 10% of shares, and added more than 10 million shares in Q1. T. Rowe Price added nearly 7 million shares in the same period. FMR added 14 million shares through February. That institutional buying pattern, with several large managers adding meaningfully through the first quarter, sits against the backdrop of insider selling. On April 8, four senior executives — including the CFO and two divisional COOs — sold a combined total of approximately CAD 5.5 million worth of stock. The trades were at prices between CAD 64 and CAD 68, which is above the current close, and all carried low significance scores. These look like routine planned disposals rather than a directional signal, but the optics of clustered senior selling one day before a sharp market dip are worth registering.
With Q1 results due May 7, the most relevant precedent in the data is the last print, in early March, which pushed the stock up 4.5% in a single session and 9.8% over the following week. The pattern suggests CNQ has rewarded patience around earnings. The question for the week ahead is whether the fresh short interest that arrived around April 21 reflects genuine conviction about the Q1 print, or simply tactical positioning into an oil-price-sensitive name ahead of a volatile macro backdrop. The CTB spike on April 28 will be the metric to watch for evidence of a squeeze if the results surprise to the upside.
See the live data behind this article on ORTEX.
Open CNQ on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
